The MI World Summit 2026 provides perspectives on radiopharmaceutical development, theranostic delivery models, regional access considerations, and approaches to implementing theranostics across different healthcare settings. Sessions explore operational, clinical, and infrastructure topics shaping theranostics programs around the world.
Advancing theranostics audiocast
Coming soon
Advancing theranostics article
Coming soon
Overview article
Featured recordings
Future-proofing theranostics: Lessons learned building a molecular imaging center of excellence
Ryan Avery, MD
Theranostics delivery: Academic tier 1
Philipp Backhaus, MD
Theranostics delivery: Closing the gap—Meaningful access
via outpatient theranostics
Munir Ghesani, MD, FACNM, FACR, FSNMMI
Theranostics delivery: An ICON and Australasian perspective
Nat Lenzo, MD, MS (Oncol), MBA
Computational nuclear oncology, theranostic digital twins, and predictive dosimetry towards precision radiopharmaceutical therapies
Arman Rahmim, PhD, DABSNM, FSNMMI
Advancing theranostics— Innovations needed for a sustained transformation of nuclear medicine
Michael Schäfers, MD
Scaling theranostics for
greater patient access
Ishita B. Sen, MD
Explore other MI World Summit sessions
